Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT02257632 · COMPLETED
Trial details
- NCT number
- NCT02257632
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-08
- Primary completion
- 2017-03-20
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.